P NATL ACAD SCI USA 润色咨询

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

出版年份：1915 年文章数：71052 投稿命中率： 开通期刊会员，数据随心看

出版周期：Weekly 自引率：2.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2024-02-26 123bc054m90暂无昵称 来自山东省

    文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2024-02-15 ms6000001790334235 来自重庆

    学到了很多

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2023-07-05 ms4000001367023473 来自山东省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：发育
    经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2022-06-09 osmataku

    收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions...

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2022-05-10 ms1000000471957018

    偏重的研究方向：微生物
    经验分享：iii

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2022-04-20 Mis 吴

    偏重的研究方向：药理学
    经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2022-04-14 ms7000000308199462

    偏重的研究方向：生物学
    经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2022-03-08 雪花莹

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2021-07-20 ms5000000115506285

    Stage Start Date
    Under Review 2021-07-19
    Under Editor Review 2021-07-18
    Under Editorial Board Review 2021-07-14
    Quality Control Review Completed 2021-07-14
    Quality Control Issue Identified 2021-07-13
    Quality Control Review Started 2021-07-11
    Author Approved Submission 2021-07-11
    Preliminary Manuscript Information Submitted 2021-07-11

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：发育<br>经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物<br>经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学<br>经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学<br>经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001183, encodeId=adfd1001183ea, content=Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:31:38 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=862003, encodeId=770e862003cd, content=大家别理楼下这个nt 不知道从哪个精神病院跑出来了<br> 一会工程 一会农业 一会医学<br> 连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊 <br> 这不是杂志社派来的就是精神有问题<br> 国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Wed Jun 17 00:41:03 CST 2020, time=2020-06-17, status=1, ipAttribution=)]
    2020-06-17 ms5532630230796179

    大家别理楼下这个nt 不知道从哪个精神病院跑出来了
    一会工程 一会农业 一会医学
    连nc是英国杂志都不知道就出来各种怼nc pnas cns然后海吹国产垃圾期刊
    这不是杂志社派来的就是精神有问题
    国内科研圈真的是乌烟瘴气 怪不得cell research都冲到20了都还是个畸形期刊 水平还不如cell reports

    0

共181条页码: 3/19页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分